1048360-18-4

Basic information

• Product Name: {2-[boc-Arg(Pbf)]-aminoethyl}methylcarbamic acid benzyl ester
• Synonyms: {2-[boc-Arg(Pbf)]-aminoethyl}methylcarbamic acid benzyl ester
• CAS NO: 1048360-18-4
• Molecular Weight: 716.899
• Mol File: 1048360-18-4.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: {2-[boc-Arg(Pbf)]-aminoethyl}methylcarbamic acid benzyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: {2-[boc-Arg(Pbf)]-aminoethyl}methylcarbamic acid benzyl ester(1048360-18-4)
• EPA Substance Registry System: {2-[boc-Arg(Pbf)]-aminoethyl}methylcarbamic acid benzyl ester(1048360-18-4)

Safety Data

• Hazardous Substances Data: 1048360-18-4(Hazardous Substances Data)

Upstream product

• 186698-61-3 (S)-2-(tert-butoxycarbonylamino)-5-(3-(2,2,4,6,7-pentamethyl-2,3-dihydrobenzofuran-5-ylsulfonyl)guanidino)pentanoic acid 
• 19023-94-0 (2-aminoethyl)-methylcarbamic acid,benzyl ester 
• 1221593-52-7 methyl-[2-(2,2,2-trifluoro-acetylamino)-ethyl]carbamic acid benzyl ester 
• 200124-22-7 Boc-Arg-(Pbf)-OH 
• 162576-01-4 2-(aminoethyl)methylcarbamic acid benzyl ester hydrochloride 

Downstream Products

• 1048360-17-3 {2-[H-Arg(Pbf)]aminoethyl}methylcarbamic acid benzyl ester 
• 1276122-67-8 {2-[2-tert-butylmalonyl-Arg(Pbf)]aminoethyl}methylcarbamic acid benzyl ester 
• 1345532-66-2 N-[(S)-1-(2-([3-((1R,2R)-3-dimethylamino-1-ethyl-2-methyl-propyl)-phenoxycarbonyl]-methyl-amino)-ethylcarbamoyl)-4-guanidino-butyl]-malonamic acid trifluoroacetate 
• 1345532-64-0 N-((S)-1-(2-([3-((1R,2R)-3-dimethylamino-1-ethyl-2-methyl-propyl)-phenoxycarbonyl]-methyl-amino)-ethylcarbamoyl)-4-(2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl-guanidino)-butyl)-malonamic acid tert-butyl ester 

Relevant articles and documents

Pharmaceutical compositions with attenuated release of phenolic opioids

Pharmaceutical compositions and their methods of use are provided, where the pharmaceutical compositions comprise a phenolic opioid prodrug that provides enzymatically-controlled release of a phenolic opioid, and an enzyme inhibitor that interacts with th

Active agent prodrugs with heterocyclic linkers

The embodiments provide prodrug compounds of Formulae I-XVII. The present disclosure also provides compositions, and their methods of use, where the compositions comprise a prodrug compound of Formulae I-XVII that provides controlled release of an active agent. Such compositions can optionally provide a trypsin inhibitor that interacts with the enzyme that mediates the controlled release of an active agent from the prodrug so as to attenuate enzymatic cleavage of the prodrug.

COMPOSITIONS COMPRISING ENZYME-CLEAVABLE OPIOID PRODRUGS AND INHIBITORS THEREOF

Pharmaceutical compositions and their methods of use are provided, where the pharmaceutical compositions comprise an opioid prodrug that provides enzymatically-controlled release of an opioid, and an enzyme inhibitor that interacts with the enzyme(s) that mediates the enzymatically-controlled release of the opioid from the opioid prodrug so as to attenuate enzymatic cleavage of the opioid prodrug.